Sensus Healthcare Inc. (SRTS)
| Bid | 4.58 |
| Market Cap | 76.13M |
| Revenue (ttm) | 41.81M |
| Net Income (ttm) | 6.65M |
| EPS (ttm) | 0.41 |
| PE Ratio (ttm) | 11.26 |
| Forward PE | 7.69 |
| Analyst | Buy |
| Ask | 4.8 |
| Volume | 84,272 |
| Avg. Volume (20D) | 289,204 |
| Open | 4.69 |
| Previous Close | 4.72 |
| Day's Range | 4.58 - 4.74 |
| 52-Week Range | 3.16 - 9.33 |
| Beta | 1.11 |
About SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and s...
Analyst Forecast
According to 3 analyst ratings, the average rating for SRTS stock is "Buy." The 12-month stock price forecast is $13, which is an increase of 181.69% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago · businesswire.com
Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial ResultsBOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...
